Breaking News
Top News
-
Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today
-
Purdue Pharma to Pay $225 Million to Justice Department
-
Robinhood Markets Q1 Earnings Call Highlights
-
South Plains Financial Q1 Earnings Call Highlights
-
National Research Q1 Earnings Call Highlights
-
Porch Group Q1 Earnings Call Highlights
-
OPKO Health Q1 Earnings Call Highlights
-
T-Mobile US Q1 Earnings Call Highlights
-
Zimmer Biomet (ZBH) Plunges to 13-Year Low on Finance Chief Resignation
-
Barclays, Mizuho Offer Mixed Views on American Tower (AMT)
-
Qiagen NV (QGEN) Falls to 7-Year Low as MidEast Tensions Drag Q1
-
Citi, RBC Capital See Improving Broadband Trends at Comcast (CMCSA)
-
Alexandria Real Estate (ARE) Nears 17-Year Low as Analyst ‘Bearish’
-
Morgan Stanley Updates Utility Outlook, Lowers View on Edison International (EIX)
-
Sportradar (SRAD) Hits 52-Week Low on Dismal Q1, 14.3% PT Downgrade
-
T. Rowe Price Group (TROW) – Among the 10 Best High-Yield Dividend Growth Stocks to Buy Right Now
-
Is Hormel Foods (HRL) One of the Best High-Yield Dividend Growth Stocks to Buy Right Now?
-
Relay Therapeutics (RLAY) Falls Hard on Profit-Taking From 74% April Jump
-
Celestica (CLS) Plunges 14% After All-Time High — Here’s What Dragged Sentiment
-
Navitas (NVTS) Nosedives on Profit-Taking as Firm Gains Over 100%
2026-02-05




















